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Abstract: Phagocytosis of invading microorganisms by
specialized cells such as macrophages and neutrophils is a
key component of the innate immune response. These
cells capture and engulf pathogens and subsequently
destroy them in intracellular vacuoles—the phagosomes.
Pathogen phagocytosis and progression and maturation
of pathogen-containing phagosomes, a crucial event to
acquire microbicidal features, occurs in parallel with
accentuated formation of lipid-rich organelles, termed
lipid bodies (LBs), or lipid droplets. Experimental and
clinical infections with different pathogens such as
bacteria, parasites, and viruses induce LB accumulation
in cells from the immune system. Within these cells, LBs
synthesize and store inflammatory mediators and are
considered structural markers of inflammation. In addition
to LB accumulation, interaction of these organelles with
pathogen-containing phagosomes has increasingly been
recognized in response to infections and may have
implications in the outcome or survival of the microor-
ganism within host cells. In this review, we summarize our
current knowledge on the LB-phagosome interaction
within cells from the immune system, with emphasis on
macrophages, and discuss the functional meaning of this
event during infectious diseases.
Introduction
Phagocytosis of invading microorganisms by specialized cells
such as macrophages and neutrophils is a key component of the
immune innate response. Phagocytosis is also a fundamental
process for removal of cells undergoing apoptosis. The first stage of
the elimination process is the internalization of the pathogens or
apoptotic bodies into a plasma membrane-derived vacuole, known
as phagosome (Figure 1A and 1B). Newly formed phagosomes,
however, lack the ability to kill pathogens or to degrade the
ingested targets. These properties are acquired during the course
of phagosome maturation when the phagosome membrane and
contents undergo considerable remodeling to transform the
initially inert environment into a microbicidal one. Phagosomes
mature by sequential fusion with endocytic (early and late
endosomes) and lysosomal compartments culminating with the
formation of the phagolysosome (Figure 1C), a highly acidic (pH
between 4.0 and 5.0) compartment, in which the ingested
pathogen is degraded (reviewed in [1,2]).
In cells from the immune system, mainly macrophages, both
pathogen phagocytosis and progression of pathogen-containing
phagosomes generally occurs in parallel with accentuated forma-
tion of lipid-rich organelles, termed lipid bodies (LBs) or lipid
droplets [3–7]. These organelles, largely associated with lipid
storage in the past, are now recognized as dynamic and
functionally active organelles, involved in a variety of functions
such as lipid metabolism, trafficking, and signaling. LBs have also
attracted considerable attention due to their link with human
diseases such as obesity, inflammatory diseases, and cancer
(reviewed in [8–10]). Experimental and clinical infections with
different pathogens such as bacteria [3,4,11–15], parasites [5–
7,16,17], and viruses [18,19] induce LB accumulation within
different cell types. One intriguing aspect of LBs formed in
response to infections is the ability of these organelles to relocate in
the cytoplasm and interact with phagosomes, suggesting a
significant and yet ill-understood association between these
structures [3–6,12,14]. This interaction occasioned attention
because it may have implications for the microorganism outcome
or survival within host cells. Here, we summarize our current
knowledge on the LB-phagosome interaction within cells from the
immune system, with emphasis on macrophages, key players in the
initial resistance to the infection, and discuss the functional
meaning of this event during infectious diseases.
LB Structure and Composition
LBs are intracellular organelles of all cell types including plants
and microorganisms (reviewed in [20]). Despite variations in
function, appearance, and composition between different organ-
isms and their cell types, all LBs are recognized by a distinctive
architecture—the presence of a core containing neutral lipids
mainly tryacylglycerols (TAG) and sterol esters (SE) surrounded by
a phospholipid hemimembrane with associated proteins [20,21].
Therefore, in contrast to all cytoplasmic organelles and vesicles
that have an aqueous content surrounded by a phospholipid
bilayer membrane, the LB surface lacks a delimiting unit
membrane structure (Figure 2). This unique feature of LBs
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PLoS Pathogens | www.plospathogens.org 1 July 2012 | Volume 8 | Issue 7 | e1002729facilitates the identification of these organelles by transmission
electron microscopy (TEM) compared to other intracellular
membranous organelles (Figure 2) [6].
LBs contain a collection of proteins with numerous biological
functions. LB-specific structural proteins, the PAT family of
proteins (recently renamed to perilipin family proteins [22])—
perilipin/PLIN1, adipose differentiation-related protein (ADRP/
Adipophilin/PLIN2) [23], and tail-interacting protein of 47 kDa
(TIP47/PLIN3) [24]—are constitutively associated with the
circumferential rim of LBs (Figure 2) and participate in the
Figure 1. Ultrastructure of nascent phagosomes and phagolysosomes within phagocytic cells in a murine model of tuberculosis. (A)
Nascent phagosomes containing phagocytosed mycobacteria (arrows) are seen in the cytoplasm of a neutrophil. In (B), macrophage pseudopods
encircle an apoptotic cell (arrowheads). (C) Typical phagolysosomes (Ph) within a macrophage show heterogenous content and varying sizes and
electron-density. A degenerating bacterium is observed (arrow). Mice were infected with Mycobacterium bovis bacillus Calmette-Guerin (BCG) and
cells from the pleural cavity processed for transmission electron microscopy as before [3]. Scale bars, 1 mm (A, B), 500 nm (C).
doi:10.1371/journal.ppat.1002729.g001
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lipid metabolism, membrane trafficking proteins including small
GTPases of the Rab family (critical regulators of vesicular traffic
and organelle interaction), endoplasmic reticulum (ER) proteins,
and molecular chaperones are frequently identified in LB fractions
(Figure 2) [26]. In fact, a growing list of proteins, provided mainly
Figure 2. Lipid body (LB) structure and composition. (Ai–Aiii) A LB within a human blood eosinophil is observed by transmission electron
microscopy (TEM) at different magnifications (boxed area in Ai is shown in Aii and Aiii). LBs are delimited by a monolayer of phospholipids differing
from the structural organization (phospholipid bilayer membrane) of all other organelles, vesicles, and plasma membrane (arrowheads in Aii and box
in Aiii). Structural proteins from the perilipin family are associated with the LB surface while the LB core contains mainly sterol esters (SE),
triacylglycerols (TAG), diacilglycerols (DAG), and cholesterol. Numerous proteins are frequently found in LBs such as Rab GTPases, lipid metabolism
enzymes, kinases, caveolins, and chaperones. Nu, nucleus; Gr, secretory granule. Scale bar, 600 nm.
doi:10.1371/journal.ppat.1002729.g002
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summarized in several reviews [27–29]. The LB protein compo-
sition greatly varies depending on the cell type and its
physiological state. Interestingly, LBs may act as platforms for
managing the availability of proteins, functioning as transient sites
for proteins that will be released, delivered, or destructed [30].
However, how proteins are specifically targeted to LBs is still
poorly understood.
It has been recognized that proteins are not restricted to the LB
surface, but they are also embedded in the LB core. For example,
freeze-fracture immunocytochemistry and EM revealed that
perilipin, caveolin-1, ADRP, and TIP47 are present in the LB
cores of adipocytes and macrophages [31]. How polar proteins
such as TIP47 and ADRP are arranged within these organelles
remains to be defined.
LB Composition in Cells from the Immune System
As noted, LBs within a cell differ regarding function and
metabolic status and these characteristics are reflected in their
composition. In cells from the immune system, LBs are recognized
as sites for generation of inflammatory mediators (eicosanoids) and
therefore have specific molecules linked to this synthesis (reviewed
in [8,32]).
LBs from macrophages, eosinophils, neutrophils, and mast cells
contain stores of arachidonic acid (AA) associated with pools of
phospholipid and/or neutral lipids [33–35]. AA is a 20-carbon
fatty acid and a key signaling molecule acting as intracellular
second messenger, as paracrine mediator of cell activation, and as
a substrate for enzymatic conversion into eicosanoids [36].
The major enzymes involved in the enzymatic conversion of AA
into eicosanoids are also present within LBs from activated cells of
the immune system, mainly macrophages, eosinophils, and
neutrophils. These enzymes include cyclooxygenases (COX)
[3,7,33,37–39], 5-and 15-lypoxygenases (5-LO and 15-LO)
[39,40], and leukotriene C4 (LTC4)-synthase [39]. Moreover,
phospholipase A2 (cPLA2) and its activating protein kinases,
mitogen-activated protein (MAP) kinases (ERk1, ERK2, p85, and
p38), the upstream involved in AA liberation, have been described
within LBs [41].
Overall, LBs from cells of the immune system compartmentalize
the substrate (AA) and the entire enzymatic machinery for
eicosanoid synthesis. Because eicoisanoids are non-storable medi-
ators, newly formed and rapidly released upon cell stimulation, the
detection of these molecules is not simple. However, by means of a
new strategy to cross-link newly formed eicosanoids at its sites of
synthesis, the presence of eicosanoids has been directly demonstrat-
ed within LBs [42]. prostaglandin E2 (PGE2) was found in LBs from
mouse macrophages infected with Mycobacterium bovis BCG, which
causes bovine tuberculosis [3], or with the intracellular protozoan
parasite Trypanosoma cruzi, the causal agent of Chagas’ disease, a
debilitating cardiac illness [7]; LTC4 was demonstrated in LBs from
human eosinophils and basophils stimulated with the chemokines
eotaxin/CCL11 and RANTES/CCL5 [43] and in eosinophil LBs
from murine models of allergic inflammation [44], and LTB4in LBs
from neutrophils and macrophages during sepsis [45].
In summary, there is good evidence that LBs are able to change
their composition in concert with cell activation acting as
inflammatory organelles with roles in the innate immune response
to infections and inflammatory processes.
Pathogen Induction of LB Formation
Pathogens induce several changes in the host cell signaling and
trafficking mechanisms. One prominent pathogen-mediated
change is the formation of LBs in the host cell cytoplasm. Most
cells contain a small number of cytoplasmic LBs, but they can be
rapidly stimulated to form new LBs under interaction with
pathogens. This interaction is also able to increase LB size and to
induce LB ultrastructural alterations. LB biogenesis is a process
that happens in vivo and in vitro in response to a variety of
pathogens.
Parasites
The first observation of newly formed LBs in response to an in
vivo parasite infectious disease dates to 2003 [5]. By investigating
inflammatory macrophages from rats infected with a virulent
strain of T. cruzi (Y strain), a significant increase of the LB numbers
in peritoneal macrophages at day 6 and 12 of the infection was
found. While control peritoneal macrophages presented
,2.1960.4 (mean 6 SEM) LBs/cell, peritoneal macrophages
from infected animals showed ,18.0961.4 LBs/cell at day 12 of
infection. At this time, the most intense inflammatory process and
parasitism in the heart, a target organ of Chagas’ disease,
compared to other points during the acute phase in rats, is
observed [5]. Accordingly, inflammatory macrophages recruited
to the heart exhibited a striking increase in LB numbers (Figure 3)
[5]. T. cruzi is also capable to induce in vitro LB formation within
mouse peritoneal macrophages through a Toll-like receptor -2
(TLR2)-dependent mechanism [7]. At 24 h of murine infection,
both the cells containing internalized parasites as well non-
parasitized cells showed an increased number of LBs compared to
control, non-infected cells, suggesting a bystander amplification of
the response [7]. Interestingly, parasitized cells showed a
significantly higher number of LBs (3-fold) compared to non-
parasitized cells, demonstrating that the uptake of the parasite
directly induces LB biogenesis [7].
Pathological studies of target organs of malaria, such as kidney
and liver, found the presence of a high number of LBs in infected
mice, indicating that the parasite Plasmodium berghei, the causative
agent of the disease, induces LB accumulation in host cells [46,47].
Other parasites such as Toxoplasma gondii, which causes human
toxoplasmosis [16], and Leishmania amazonensis, a causal agent of
human leishmaniasis [48], trigger LB formation during the in vitro
infection of human fibroblasts and mouse peritoneal macrophages,
respectively.
Bacteria
Interaction of pathogenic bacteria with host cells leads to LB
biogenesis. Tuberculosis caused by Mycobacterium tuberculosis is
characterized by a tight interplay between M. tuberculosis and host
cells within cellular aggregates (granulomas) [4,49]. The induction
of foamy macrophages—a granuloma-specific cell population
characterized by its high lipid content compartmentalized in
LBs—has been extensively reported during the progression of
tuberculosis caused by M. tuberculosis in both humans and
experimental settings [4,13,49]. In experimental studies with
Mycobacterium bovis bacillus Calmette-Guerin (BCG), it was found
that this pathogen is capable of inducing a dose- and time-
dependent increase on LB formation within pleural macrophages
[3]. LB formation initiates rapidly and significantly increased LB
numbers are noted within 1 h, reaching maximum levels within
24 h, and remaining increased for at least 15 d after BCG
infection [3]. Remarkably, nonsteroidal anti-inflammatory drugs
(NSADs), such as aspirin and NS-398, drastically inhibited M. bovis
BCG-induced LB formation within 24 h. In parallel, the BCG-
induced PGE2 generation was completely abrogated [3].
Accumulation of lipid-filled foamy macrophages is also a
hallmark of lepromatous leprosy, a chronic disease caused by
PLoS Pathogens | www.plospathogens.org 4 July 2012 | Volume 8 | Issue 7 | e1002729Mycobacterium leprae. Leprosy is characterized by widespread skin
lesions in which M. leprae lives and replicates in foamy
macrophages. These macrophages are highly positive for ADRP
[11,50] and perilipin [50]. Moreover, M. leprae infection increases
expression of ADRP/perilipin mRNA in THP-1 cells, a human
promonocytic cell line [50]. These observations indicate that the
foamy aspect of macrophages is derived from LB accumulation
induced during M. leprae infection. In fact, the capacity of M. leprae
to induce LB formation was confirmed in vivo via an experimental
model of mouse pleurisy and in in vitro studies with human
monocytes and murine peritoneal macrophages [11].
LB formation within macrophages is also driven by infection
with Chlamydia pneumonia and characterizes the early atherosclerosis
in the presence of low-density lipoprotein (LDL) [15]. More
Figure 3. Lipid bodies (LBs) increase in number and interact with phagosomes within heart inflammatory macrophages during
parasite infection. LBs with different sizes are seen as electron-dense or electron-lucent organelles surrounding and in contact (arrow) with a large
phagolysosome containing an intact amastigote (*), the intracellular form of the parasite Trypanosoma cruzi. Rats were infected with the Y strain of T.
cruzi and samples of the heart, a target organ of the parasite, processed for transmission electron microscopy at day 12 of infection [6,68,69]. Nu,
nucleus. Scale bar, 800 nm.
doi:10.1371/journal.ppat.1002729.g003
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with Chlamydia muridarum, which causes genital infection in mice,
demonstrated that epithelial host cells accumulate LBs in parallel
to bacteria replication [51].
Interestingly, the bacterium uptake does not seem essential for
LB formation within macrophages and other cells. In human
peripheral blood monocytes and murine macrophages exposed to
M. leprae, LB biogenesis is observed in the cytoplasm of both cells
bearing bacteria and cells with no bacteria [11]. However, as
noted in macrophages cultured with T. cruzi [7], cells with
internalized pathogens showed higher LB formation compared to
cells that were exposed to the pathogens but did not engulf them
[11], indicating that phagocytosis potentiates LB biogenesis.
Bacterial derivates such as lipopolysaccharide (LPS) present in
all Gram-negative bacteria [15,52] and the mycobacterial cell wall
component lipoarabinomannan (LAM), a virulence factor of M.
tuberculosis [3], are also able to induce LB formation in
macrophages.
Distinct signaling pathways can trigger LB formation within
cells from the immune system. Specific bacteria- and receptor-
mediated pathways activate intracellular signaling that leads to
enhanced LB formation. For instance, M. bovis BCG [3], but not
the non-pathogenic bacteria Mycobacterium smegmatis or Bacillus
subtilis [3], induces toll-like receptor 2 (TLR2)-mediated formation
of LBs in macrophages; TLR6 but not TLR2 drives LB biogenesis
in M. leprae-infected Schwann cells [53], and TLR2 but not TLR4
are involved in the formation of LBs in macrophages infected with
Chlamydia pneumonia [15].
Viruses
LB formation is also induced by infection with viruses such as
the hepatitis C virus (HCV), the major causative pathogen
associated with liver cirrhosis and hepatocellular carcinoma [18],
and dengue virus (DENV), an emerging viral disease transmitted
by arthropods to humans in tropical countries [19]. Pharmaco-
logical inhibition of LB formation greatly decreases DENV and
HCV replication [19,54], suggesting LBs as targets for antiviral
strategies.
A list of pathogens that induce LB biogenesis within different
mammalian cells is shown in Table 1.
Pathogen-Mediated LB Structural Changes
Newly formed LBs within pathogen-infected macrophages can
show changes in size and ultrastructure. In scoring the diameters
of LBs within inflammatory macrophages from rats experimentally
infected with T. cruzi, 74% of LBs had a size ,0.5 mm in non-
infected whereas 54% of LBs from infected animals were
.0.5 mm, reaching up to 3 mm. When macrophages from T.
cruzi-infected animals were challenged in vivo with higher parasite
load, a significant increase of LB sizes compared to LBs induced
by the infection alone was observed [6].
One interesting ultrastructural aspect of LBs is their electron-
density (osmiophilia), which is dependent on the cell type and can
change in response to pathogens. When observed by TEM,
macrophages from mice infected with M. bovis BCG show distinct
morphology, becoming larger and less dense organelles compared
to LBs from non-infected cells [3]. Accordingly, LBs formed in
response to the in vivo T. cruzi infection within inflammatory
macrophages also exhibited changes in electron-density compared
to uninfected cells [6]. Interestingly, LBs change their electron-
density in macrophages stimulated in vivo with higher parasite
load. Rats were exposed to a single, high dose of gamma
irradiation 1 d before infection, which depletes the humoral and
cellular immune responses except for the phagocytic activity of
macrophages. Inflammatory macrophages from irradiated-infect-
ed animals showed an increase in the numbers of both light-dense
and strongly electron-dense LBs compared to infection alone [6].
Pathogen-mediated LB morphological changes may reflect differ-
ences in lipid or protein composition, stages of formation of new
LBs, mobilization, and/or neutral lipids/phospholipids ratio
within LBs [6].
Interaction of LBs with Phagosomes
The first documentation of a significant interaction between LBs
and phagosomes dates to 1983 [55]. In an autoradiographic
ultrastructural study of the incorporation of
3H AA by macro-
phages that were also exposed to zymosan particles for phagocy-
tosis, a striking approximation of
3H AA-incorporated LBs with
phagolysosomes was observed (Figure 4). Moreover,
3H AA-
labeled LBs occasionally fused with phagolysosomes membranes
and many cells exhibited autoradiographic grains over phagolyso-
somes (Figure 4) [55]. This was the first evidence that LBs not only
were able to associate with phagosomes but also discharged their
contents into these structures [55]. However, this interaction
received scant attention for two decades.
In 2003, a study of inflammatory macrophages triggered by the
in vivo infection with T. cruzi demonstrated a clear association of
LBs with phagosomes in parallel to LB formation (Figures 3 and 5)
[5]. Detailed quantitative TEM analyses of the LB-phagosome
interaction induced by the experimental T. cruzi infection revealed
that 47% of newly formed LBs were associated with phagolyso-
somes within inflammatory macrophages, mainly in the heart. LBs
were seen surrounding or attached to phagosomes (Figures 3 and
5) and even within the lumen of these structures (Figure 5),
indicating that the LB-phagosome interaction can result in LB
internalization into parasite-containing phagosomes [6]. Later the
identification by TEM of LB-phagosome interaction in macro-
phages from both animal models and humans infected with
mycobacteria brought new attention to LBs as organelles
connected with the life cycle of pathogens [3,4].
Other studies have been demonstrating LB translocation into
the lumen of bacteria-containing phagosomes using live cell
fluorescence microscopy and/or TEM [12,14,51]. In an experi-
mental model of infection with the intracellular pathogen
Chlamydia trachomatis, which causes several ailments such as
trachoma, conjunctivitis, epididymitis, and pelvic inflammatory
disease, it was shown that LBs dock at the surface of the bacteria-
containing vacuole (termed ‘‘inclusions’’) within Hep2 or HeLa
cells, penetrate the vacuole membrane, and intimately associate
with reticulate bodies, the replicative form of Chlamydia [14,56].
Nerve biopsies of patients infected with M. leprae also show
accumulating LBs in close association with M. leprae-containing
phagosomes within Schwann cells, a target cell of this pathogen.
These LBs are then promptly recruited to the bacteria-containing
phagosomes, a process that depends on cytoskeletal reorganization
and phosphatidylinositol 3 kinase (PI3K) signaling [12]. Thus, the
lipid-laden, bacterial-bearing vacuoles observed in heavily infected
SCs in lepromatous leprosy nerve biopsies might be formed by the
continuous formation and recruitment of LBs, giving rise to their
foamy appearance [12]. Another in vivo study using a model of
intracervical murine infection with Chlamydia muridarum demon-
strated the same phenomenon—multiple LBs in contact with the
pathogen-containing vacuole and LBs entering into the vacuole
within host cells [51].
Overall, infection with different pathogens leads to movement of
LBs into phagosomes. It is intriguing how pathogens target LB and
how intact and non-membrane-bound organelles such as LBs are
PLoS Pathogens | www.plospathogens.org 6 July 2012 | Volume 8 | Issue 7 | e1002729Table 1. Pathogen-induced lipid body (LB) formation and LB-phagosome interaction in mammalian cells.
Pathogen LB Formation LB-Phagosome Interaction Cell Type Organism Refs
Bacteria
Acinetobacter baumannii + n.d. J774 macrophages Mouse [70]
Bacillus subtilis 22 Macrophages Mouse [3]
Chlamydia muridarum ++ Epithelial cells
(cervix)
Mouse [51]
Chlamydia pneumoniae + n.d. Macrophages Mouse [15]
Chlamydia trachomatis ++ Hep2 cell line Human [56]
++ HeLa cell line Human [14]
Escherichia coli n.d. + THP-1 cell line
(macrophage-like)
Human [61]
+ n.d. J774 macrophages Mouse [70]
Klebsiella pneumonia + n.d. Peripheral blood
monocytes
Human [70]
+ n.d. J774 macrophages Mouse [70]
Mycobacterium bovis BCG ++ Pleural macrophages Mouse [3]
Mycobacterium leprae + n.d. Skin macrophages Human [11]
+ n.d. Peripheral blood
monocytes
Human [11]
+ n.d. Peritoneal macrophages Mouse [11]
+ n.d. Pleural macrophages Mouse [11]
++ Schwann cells Human [12]
Mycobacterium smegmatis 22 Macrophages Mouse [3]
Mycobacterium tuberculosis ++ Foamy macrophages
(granuloma)
Human [4]
+ n.d. Macrophages Human [13]
Proteus vulgaris + n.d. J774 macrophages Mouse [70]
Pseudomonas aeruginosa + n.d. J774 macrophages Mouse [70]
Pseudomonas diminuta + n.d. J774 macrophages Mouse [70]
Staphylococcus aureus + n.d. J774 macrophages Mouse [70]
Staphylococcus epidermidis + n.d. J774 macrophages Mouse [70]
Staphylococcus salivarius + n.d. Peripheral blood
monocytes
Human [70]
+ n.d. J774 macrophages Mouse [70]
Vibrio cholera + n.d. Mucosal mast cells Human [71]
Bacteria Derivates
CpG-DNA + n.d. J774 macrophages Mouse [70]
Flagellin + n.d. J774 macrophages Mouse [70]
LPS (lipopolysaccharide) + n.d. Macrophages Mouse [15,52,70]
LAM (lipoarabinomannan) + n.d. Macrophages Mouse [3]
Parasites
Leishmania amazonensis + n.d. Peritoneal
macrophages
Mouse [48]
Plasmodium berghei + n.d. Kidney cells Mouse [47]
+ n.d. Liver cells Mouse [46]
Schistosoma mansoni derivates + n.d. Eosinophils Mouse [17]
Toxoplasma gondii + n.d. Fibroblasts Human [16]
Trypanosoma cruzi ++ Heart macrophages Rat [5,6]
++ Peritoneal
macrophages
Rat [5,6]
+ n.d. Peritoneal
macrophages
Mouse [7]
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seem to be involved in capturing LB into bacteria-containing
vacuoles while the translocation process seems to involve
displacement of the LB structural protein ADRP from the LB
surface to the phagosome membrane, as observed during the in
vitro infection with Chlamydia trachomatis [14]. Interestingly, both
ADRPand perilipin, were alsoimmunolocalized on the membranes
of bacilli-containing phagosomes in macrophages from skin biopsy
specimens from patients with lepromatous leprosy [50]. However,
the mechanistic details underlying the LB-phagosome interaction
require further investigations to be deciphered.
LB-phagosome association has also been observed in other
situations. Contact sites between LBs and latex bead-containing
phagosomes were identified by high resolution Raman microscopy
in neutrophilic granulocytes [57] and by fluorescence microscopy
in dendritic cells [58]. By using time-lapse fluorescence microsco-
py, it was pointed out that the LB-phagosome association within
neutrophilic granulocytes seems transient, similar to ‘‘kiss-and-
run’’ behavior displayed by endosomes involved in phagosome
maturation [57]. LBs were also observed in close contact with
nascent autophagosomes within normal rat kidney (NRK) cells
[59],butthebiologyofLBsduringautophagy isstillnotunderstood.
LB-Phagosome Interaction: Functional
Implications
As noted, the LB-phagosome interaction seems to be a general
event found during infections with different pathogens in both
humans and experimental models. Although little is known about
the functional meaning of this interaction, it raises intriguing
possibilities in light of the LB composition and functions.
Much interest has been focused on LBs as conduits for the
transport of potential nutrients, especially neutral lipids, to the
phagosome. The lipid content of LBs may, therefore, serve as a
nutrient source for the pathogen enabling its survival within the
cell [3,4,12,14,53]. The LB-phagosome interaction has been
considered as a pathogen strategy for accessing host lipids during
M. tuberculosis [4] and M. leprae [12] human infections and
experimental infection with Chlamydia trachomatis [14]. Considering
that M. tuberculosis bacilli are able to accumulate lipids during
dormancy from which it derives both carbon and energy for its
own metabolism [60], the mycobacteria-phagosome interaction
could be important for the pathogen growth and persistence [3,4].
Pharmacological inhibition of LB formation within pathogen-
infected cells was investigated. Using triacsin C, which prevents
LD biogenesis by specifically inhibiting the activity of a subset of
long chain acyl-coA synthetases (ACSL) required for triacylglycer-
ide and cholesterol ester biosynthesis, a decrease was observed in
the phagosome size and reduction of chlamydial growth within
Hep2 cells [56]. The use of another inhibitor of lipid metabolism,
C75, which inhibits fatty acid synthase (FAS), inhibited not only
the M. tuberculosis-induced LB formation but also the bacterial
viability in Schwann cells [53].
The possibility of LBs to deliver other nutrients into the
phagosome for pathogen growth was also raised. Complexes of
iron and mycobactins, lipophilic siderophores of mycobacteria,
accumulate in LBs within macrophages infected with Escherichia coli
[61]. It is suggested that a subsequent migration of iron-
mycobactin complex from LBs to phagosomes would facilitate
iron delivery to phagosomal mycobacteria, acting as an iron
source for the pathogen and consequently promoting their growth
[61].
Taken together, a picture emerges in which pathogens usurp
host, newly-formed LBs to obtain nutrients, mainly lipids, as a
survival strategy. Moreover, the enhanced capacity of host cells to
generate inflammatory mediators in the course of pathogenic
infections due to increased LB formation and compartmentaliza-
tion of signaling and eicosanoid production within LBs may also
be contributing to mechanisms that intracellular pathogens have
developed to survive in host cells. For example, high concentration
of PGE2 in macrophages act as a potent inhibitor of Th1 type
response [62] and of nitric oxide (NO) production [63], creating
thus an appropriate environment for optimal pathogen growth
[63].
On the other hand, lipids have been gaining attention as co-
directors of phagocytosis (reviewed in [64]). Lipids play multiple
roles as determinants of phagosomal formation and fate and as
coordinators of the recruitment and retention of key phagocytic
proteins [64]. In M. tuberculosis-infected macrophages, selected
lipids, including AA, can activate actin assembly, phagosome-
lysosome fusion, and phagosome maturation, resulting in bacteria
killing [65]. Lipids also help to activate the phagosome-resident
enzyme nicotinamide adenine dinucleotide phosphate (NADPH)-
oxidase [66], an event essential for the degradation of microbes
upon infection [1]. Because several subunits of NADPH oxidase
depend on AA, it was suggested that the AA content of LBs are
used by phagocytes to locally activate NADPH-oxidase [57].
Key molecules, such as Rab 5 and Rab 7, are involved in the
sequential interactions of early and late endosomes with phago-
somes [1,2]. Considering that LBs are sites for these GTPases
(Figure 2) [26,67], the association of LBs with phagosomes may
constitute a mechanism for Rab transport to and from the
phagosome for phagosome maturation [57]. Igtp (Irgm
3), an ER-
resident 47 KDa immune-related GTPase involved in phagosomal
maturation and phagocytic cross-presentation, was also identified
in LBs within dendritic cells, indicating that LBs regulate cross-
Table 1. Cont.
Pathogen LB Formation LB-Phagosome Interaction Cell Type Organism Refs
Viruses
Dengue virus + n.a. BHK-21 cells Hamster [19]
Hepatitis C virus + n.a. CHO and HepG2
cell lines
Human [18]
Fungi
Candida albicans derivates + n.d. Macrophages Rat [72]
+ n.d. Hepatocytes Rat [72]
+, induced; 2, not induced; n.d., not determined; n.a., not applicable.
doi:10.1371/journal.ppat.1002729.t001
PLoS Pathogens | www.plospathogens.org 8 July 2012 | Volume 8 | Issue 7 | e1002729PLoS Pathogens | www.plospathogens.org 9 July 2012 | Volume 8 | Issue 7 | e1002729Figure 4. Human lipid bodies (LBs) observed with an ultrastructural method for autoradiography after a pulse of tritiated
arachidonic acid and exposure to zymosan. (A)
3H-arachidonate incorporated by a human macrophage is localized predominantly in LBs in
association with zymosan-filled phagosomes. In (B), a LB labeled with numerous silver grains is seen in higher magnification. Note that the labeled
lipid content is projecting into the zymosan-containing phagosome lumen. Scale bars, 1 mm (A), 600 nm (B).
doi:10.1371/journal.ppat.1002729.g004
Figure 5. Lipid bodies (LBs) translocate to phagolysosomes in infected macrophages. (Ai) LBs with different electron-densities are
observed around a large phagolysosome (outlined in red in Aii) in the macrophage cytoplasm. Note that several LBs (highlighted in yellow in Aii) are
seen within the phagolysosome. Rats were infected with the Y strain of T. cruzi and heart samples processed for transmission electron microscopy at
day 12 of infection [6,68,69]. Nu, nucleus. Scale bar, 600 nm.
doi:10.1371/journal.ppat.1002729.g005
PLoS Pathogens | www.plospathogens.org 10 July 2012 | Volume 8 | Issue 7 | e1002729PLoS Pathogens | www.plospathogens.org 11 July 2012 | Volume 8 | Issue 7 | e1002729presentation of phagocytosed antigens in these cells [58]. In
addition, the presence of contact sites between LBs and
phagosomes in dendritic cells may support a regulatory function
of LBs on phagolysosomal progression [58]. Thus, the enigmatic
LB-phagosome interaction cannot be solely viewed as a pathogen
strategy to prolong and sustain its own survival, but also might be a
host strategy to destroy or, at least, to ‘‘try’’ to kill the microbial
invader.
Summary and Perspectives
LBs emerge as key organelles involved in experimental and
clinical infections with different pathogens, such as bacteria,
parasites, and viruses. Within cells recruited in response to these
infections, especially macrophages, LBs contribute to the genesis of
inflammatory mediators and are considered as structural markers
of inflammation. In addition to LB accumulation, interaction of
these organelles with pathogen-containing phagosomes has
increasingly been recognized. Recent observations have indicated
that this intriguing and intimate association is a pathogen-driven
process, evolved as a strategy to survive within the host cells by
sequestering mainly host lipids. However, it should be noted that
the LB-phagosome interaction may be linked to defense events in
which the host cell seeks to kill the pathogen invader. Because
phagosomal membrane and luminal contents must undergo
remodeling to transform the initially inert environment into a
microbicidal one, attention should be paid to LBs as potential
determinant organelles in the phagocytic event. While this is more
speculative, to date we cannot answer whether LBs have a major
and a definitive role in the intracellular survival or destruction of
pathogens and/or if these organelles are able to interfere with
phagocytosis pathways. Other questions regarding how pathogens
target LBs and/or how LBs target pathogen-containing phago-
somes and are translocated into these vaccuoles await a lot of more
investigations. Novel approaches such as electron tomographic
analysis of the LB-phagosome interaction dynamics combined
with further refined functional analyses will be required to address
these questions. A better understanding of the cell biology of LBs
and their potential role during pathogen phagocytosis may be
crucial for the application of novel therapies addressing different
pathological conditions.
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